Clinical Reassessment: ILD + Non-Resolving Pneumonia

The Core Problem

What This Is (Most Likely)

1. Acute Exacerbation of ILD (AE-ILD) — Top Diagnosis

• Acute worsening of dyspnoea (< 1 month) in a known ILD patient
• New bilateral radiographic opacities
• Absence of an identified infectious cause (culture-negative ×2 is significant here)
• No alternative explanation (heart failure, fluid overload, PE)

2. Atypical/Opportunistic Infection Not Yet Covered

• PCP (Pneumocystis jirovecii) — especially if the patient has been on steroids or immunosuppressants for ILD (which is common). SpO2 88%, bilateral crepts, right > left, culture-negative = classic PCP presentation. High priority to rule out.
• Viral pneumonia (influenza, COVID, CMV, RSV) — not covered by any of the antibiotics used
• TB — upper lobe right-sided involvement, culture-negative TB is a known entity, especially in elderly. AFB smears, MTb PCR?
• Atypical organisms (Legionella, Coxiella/Q fever, Mycoplasma) — levofloxacin covers most of these, but urine Legionella antigen and serology should be checked

Immediate Action Plan

Investigations First (Before or Alongside Steroids)

Regarding Steroids — Yes, Add Them, But Contextually

If AE-ILD is the working diagnosis:

• Methylprednisolone 500–1000 mg IV × 3 days (pulse), then transition to oral prednisolone 1 mg/kg/day
• Some centres use prednisolone 1–2 mg/kg/day without pulse in less severe cases
• Cyclophosphamide has been added in steroid-refractory AE-ILD (referenced in Goldman-Cecil Medicine — Naccache et al.)

Critical Caveat — PCP Must Be Excluded or Covered First

• Add co-trimoxazole (TMP-SMX) empirically before starting steroids, or at least simultaneously
• Starting steroids in undiagnosed/uncovered PCP will worsen and potentially be fatal
• TMP-SMX 15–20 mg/kg/day (trimethoprim component) IV in 3–4 divided doses for severe PCP (SpO2 < 92%)
• In confirmed severe PCP, steroids are actually indicated as adjunctive therapy (prednisolone 40 mg BD × 5 days → 40 mg OD × 5 days → 20 mg OD × 11 days)

Suggested Immediate Algorithm

Culture-negative, antibiotic-refractory, known ILD, SpO2 88%
          ↓
1. HRCT chest TODAY (if not done on HRCT)
2. Bronchoscopy + BAL (PCP PCR, viral panel, AFB, fungal, cell differential)
3. Send β-D-glucan, LDH, serology
          ↓
Empirically START:
• TMP-SMX IV (covers PCP)
• Methylprednisolone pulse (if clinical picture = AE-ILD: GGO on HRCT, known ILD)
          ↓
Adjust based on BAL results

What to Rationalise Now

• Amikacin — likely not adding benefit; consider stopping unless Gram-negative cover still needed
• Linezolid — stop if no MRSA suspicion
• Piperacillin/meropenem — continue while infectious aetiology not fully excluded
• Levofloxacin — continue (covers atypicals including Legionella, Q fever)

Key Summary

This Is No Longer a Bacterial Pneumonia Problem

Reframe the Diagnosis

Most Likely: Acute Exacerbation of ILD (AE-ILD)

"Some acute exacerbations have an identifiable trigger such as pneumonia... the etiology and pathogenesis of this phenomenon remain mostly unclear." — Murray & Nadel's Textbook of Respiratory Medicine

Other Diagnoses That Must Be Actively Excluded

The Steroid Question — Answer: Yes, Add Steroids, With Conditions

For AE-ILD

"Patients who require hospitalization and intensive care for an acute exacerbation with loss of respiratory function in the absence of infection or other complications are often treated with empirical intravenous corticosteroids — methylprednisolone 1.0 g IV as a pulse dose once daily for 3 days, followed by hydrocortisone 125 mg every 6 hours for a further 3–5 days, with further dosing dependent on clinical response." — Goldman-Cecil Medicine

"Management of acute exacerbation has generally consisted of enhanced immunosuppression with pulse doses of methylprednisolone (0.5–1 g/day), sometimes combined with cyclophosphamide or cyclosporine — though no convincing evidence of benefit from controlled trials has been demonstrated." — Murray & Nadel's Textbook of Respiratory Medicine

Critical Condition Before Starting Steroids

Immediate Action Plan (Prioritised)

Step 1 — Investigations NOW (same day)

1. HRCT chest — if not already done on HRCT; CXR is inadequate. Look for:
   • Ground-glass opacity + reticulation superimposed on fibrosis = AE-ILD
   • Crazy-paving pattern = PCP
   • Upper lobe consolidation/cavitation = TB
   • Peribronchovascular/subpleural opacities = Organising Pneumonia
2. Bronchoscopy + BAL — the single most important diagnostic procedure now:
   • PCP PCR and immunofluorescence
   • Viral panel (COVID, influenza, RSV, CMV, parainfluenza)
   • AFB smear and culture, MTb NAAT (Xpert)
   • Fungal KOH, culture, galactomannan
   • BAL cell differential (lymphocytosis → HP/NSIP/OP; neutrophilia → AE-ILD/bacterial; eosinophilia → eosinophilic pneumonia)
3. Serum β-D-glucan — elevated in PCP (sensitivity ~95%)
4. Serum LDH — elevated in PCP and AE-ILD
5. Serum galactomannan — if Aspergillus suspected
6. CTPA — rule out PE (tachycardia present)
7. 2D Echo — rule out cardiac cause of non-resolving hypoxia
8. Urine Legionella antigen — if not already done
9. Connective tissue workup — ANA, anti-dsDNA, anti-MDA5, anti-Jo1 (MDA5-ILD is notorious for rapid AE-ILD with skin ulcers/palmar papules)

Step 2 — Empirical Treatment (Start Now, Adjust After BAL)

Step 3 — Review in 48–72 Hours

• If PCP confirmed on BAL → Continue TMP-SMX + add adjunctive prednisolone (40 mg BD × 5 days, taper over 21 days)
• If AE-ILD confirmed → Continue steroid pulse, consider cyclophosphamide if refractory (evidence is limited)
• If TB confirmed → Stop steroids (or taper rapidly) and start anti-TB therapy

What NOT to Do

• Do not add another antibiotic — you have maximal Gram-positive (linezolid), Gram-negative (meropenem), atypical (levofloxacin), and aminoglycoside (amikacin) cover. Escalating further serves no purpose without a culture target.
• Do not give steroids without TMP-SMX cover — if PCP is present, this will kill the patient.
• Do not delay bronchoscopy — it is the diagnostic pivot point here.

Summary

Bronchoscopy + BAL → Empirical TMP-SMX → Pulse methylprednisolone 500–1000 mg IV × 3 days

TMP-SMX Oral Dose for Suspected/Confirmed PCP

First — Classify Severity (This Determines Route)

• PaO₂ likely < 70 mmHg
• A-a gradient likely ≥ 35 mmHg

Dosing by Severity

"A typical PO dose is two double-strength tablets three times daily for 21 days. For moderate to severe disease, use IV trimethoprim-sulfamethoxazole." — Tintinalli's Emergency Medicine

If You Are Going Oral Despite Severity (practical/resource constraint):

Note from Goldman-Cecil: "Non-randomized studies have found similar efficacy but better tolerability with lower doses ≤10 mg/kg/day TMP." — useful if the patient develops adverse effects (rash, cytopenias).

Add Adjunctive Steroids If Going for PCP (Moderate-Severe)

Practical Bottom Line

TMP-SMX 2 DS tablets (320/1600 mg) orally TID × 21 days + Prednisolone 40 mg BD × 5 days then taper

PCP Risk Without Prior Immunosuppression

Classic Risk Factors for PCP

But It Is Not Zero — Ask These Questions

1. Is he on antifibrotic therapy (pirfenidone/nintedanib)? — These are not immunosuppressants, so PCP risk is not elevated by them.
2. Does he have an underlying connective tissue disease as the cause of ILD? (RA-ILD, myositis-ILD, Sjogren's-ILD) — the disease itself may cause enough immune dysregulation to permit PCP, even without drug-induced immunosuppression.
3. Is he malnourished, severely debilitated, or has he had recent rapid weight loss? — Malnutrition impairs T-cell immunity independently.
4. Any undiagnosed HIV? — Elderly males are an underscreened population. A single HIV test rules this in or out definitively.
5. Any lymphopenia on his blood counts? — CD4 lymphopenia can occur without HIV. If total lymphocyte count is low, CD4 count should be checked.

How Does This Change the Probability Assessment?

More Likely Now:

1. Acute Exacerbation of ILD (AE-ILD) — remains the top diagnosis regardless. This can happen spontaneously without any trigger in known ILD, incidence 4–15% per year in IPF. Not related to immunosuppression at all.
2. Atypical/viral pneumonia — influenza, COVID, RSV, parainfluenza — none covered by your antibiotic regimen
3. Pulmonary TB — elderly male, upper lobe right-sided, culture-negative sputum (smear-negative TB is common), no immunosuppression needed
4. Organising Pneumonia (OP) — can occur as a primary ILD subtype (COP) or secondary to infection/drug; steroid-responsive; culture-negative

Less Likely Now:

• PCP (still possible if HIV-positive or lymphopenic, but not the top pick without immunosuppression)
• CMV pneumonitis (almost always requires significant immunosuppression)

Revised Priority Differential

What This Means Practically

• TMP-SMX empirically — still reasonable to give while waiting for BAL/serology, given the low cost of treatment vs. catastrophic cost of missing PCP. But it is no longer the most urgent empirical priority.
• Get Xpert MTb/RIF on sputum or BAL immediately — TB now moves higher given the upper lobe pattern in an elderly male not on steroids.
• Send HIV test + total lymphocyte count/CD4 — takes PCP fully on or off the table.
• Pulse methylprednisolone — now more defensible, since the main reason to hesitate (uncovered PCP) is less likely in this patient.

Direct Answer: PCP Chance in This Patient?

• Has known ILD diagnosed 3 months ago
• Has never been on steroids, immunosuppressants, or antifibrotics
• Has no known HIV

Why PCP Is Unlikely Here

• CD4 count is normal
• T-cell surveillance is intact
• The organism remains as harmless colonisation, not active pneumonia

The Only Scenarios Where PCP Still Remains Possible

Practical Implication

AE-ILD > Pulmonary TB > Viral pneumonia > Organising Pneumonia

• HIV test — negative → start steroids confidently
• Xpert MTb/RIF on sputum — to rule out TB before immunosuppression
• HRCT if not done — confirms AE-ILD pattern

What to Look For on HRCT — Decision Guide

Pattern 1 → AE-ILD

• Background honeycombing / reticulation / traction bronchiectasis (pre-existing ILD)
• New bilateral ground-glass opacity (GGO) superimposed on the fibrotic background
• Subpleural / basal predominance typical, but can be diffuse

Pattern 2 → Organising Pneumonia (OP)

• Peribronchovascular or subpleural consolidation
• "Reversed halo sign" (atoll sign) — ground glass surrounded by ring of consolidation
• Migratory, patchy bilateral opacities
• No or minimal honeycombing in the new areas

Pattern 3 → Pulmonary TB

• Upper lobe consolidation (you already have right upper lobe on CXR)
• Tree-in-bud pattern — centrilobular nodules in branching pattern
• Cavitation
• Mediastinal lymphadenopathy

Pattern 4 → Viral/Atypical Pneumonia

• Bilateral GGO, often peripheral
• "Crazy paving" (GGO + interlobular septal thickening) — classic for COVID/PCP but also viral
• No underlying fibrotic background

Pattern 5 → Bacterial Consolidation Still Present

• Dense lobar / segmental consolidation
• Air bronchograms
• No GGO, no fibrotic background changes

While HRCT Is Being Done — Do These Now

Decision Flow Once HRCT Result Is Back

HRCT result
    │
    ├─ GGO on fibrotic background → AE-ILD
    │       → Pulse methylprednisolone 500–1000 mg IV OD × 3 days
    │
    ├─ Peribronchovascular consolidation → Organising Pneumonia
    │       → Prednisolone 1 mg/kg/day PO (or pulse if severe)
    │
    ├─ Tree-in-bud / cavitation / upper lobe → TB
    │       → STOP. Send Xpert. Start HRZE. No steroids.
    │
    └─ Diffuse GGO only, no fibrosis → Viral / atypical
            → Viral PCR, consider steroids if AE-ILD overlap